Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheuminations: Why the Obesity Epidemic Should Matter to Rheumatologists

Simon M. Helfgott, MD  |  Issue: January 2014  |  January 1, 2014

Can this immune metabolic link be viewed from an evolutionary perspective? Is there a biological benefit to being obese? The answer may lie in our response to infection. Bacterial infections create an acute bioenergetics demand because macrophages and T cells require circulating nutrients for an effective Th1 response and bacterial clearance. The Th1 response in AT may serve to fuel the activated immune system by promoting inflammation and insulin resistance, leading to the mobilization of nutrients via gluconeogenesis, hyperglycemia, and lipolysis.6 For most parasitic infections, however, depriving parasites of circulating nutrients is required to slow down parasite growth. Accordingly, the Th2 response in AT prevents inflammation and insulin resistance, and may serve to sequester nutrients for the host. Taken together, this energy-on-demand model presents the Th1 and Th2 responses in AT as an adaptive strategy enabling a tailored immune response against bacteria and parasites while generating deleterious effects for the host.7

Manipulating Rheumatic Disease Via Caloric Restriction

If obesity enhances inflammation, does starvation have the opposite effect? Calorie restriction remains the only dietary manipulation known to extend the lifespan of many organisms, including yeast, worms, flies, rodents, and perhaps nonhuman primates. In addition, it has been shown to reduce the incidence of age-related disorders, including diabetes, cancer, and cardiovascular disease in mammals.8

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

We know from the bedside that when caloric intake is severely restricted, patients become anergic. Simply stated, a starving immune system must conserve energy. Before the advent of corticosteroid therapy, starvation was used to treat clinically active lupus. How might it work at the molecular level? During fasting, there is a dramatic reduction in the circulating levels of leptin, an adipokine with proinflammatory effects. A recent study of a murine model of lupus demonstrated that leptin inhibits regulatory T cells, which are important drivers of peripheral immune tolerance.9 Regardless of the data, starvation therapy is unlikely to draw many adherents. Might there be more palatable measures to effectively reduce the burden of obesity-related inflammation?

Don’t Eat with Your Eyes

Joseph Delboeuf was a prolific 19th century Belgian scholar whose work in the fields of psychology and mathematics was highly respected. In 1865, he documented a puzzling illusion. Our brains can perceive a difference in the size of two identical circles when a much larger circle surrounds one, while only a slightly larger circle surrounds the other. Take a stroll down the aisles of any Pottery Barn store to see how dinnerware designers put this curious illusion to great use. A series of clever experiments led by Brian Wansink PhD, professor of consumer behavior at Cornell University in Ithaca, NY, have shown that dinner plate size and color can significantly impact the amount of food that we consume. In one study, students were asked to serve the same diameter of soup (a black spot in the center of a Delboeuf diagram) onto dinner plates of varying sizes (the outer circles of these diagrams). The researchers demonstrated that the amount of soup that was served was determined by the relative gap between the edge of the food and the edge of the dinner plate. In other words, the bigger the plate, the more soup was served.10 The students repeatedly overserved into the larger dishes and underserved into the smaller ones, and were quite unaware of their errors. These results have been replicated in other experiments. For example, children at a summer camp were found to eat less cereal when they were provided with smaller bowls.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:OpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:anti-inflammatoryeatingepidemicHelfgottMethotrexateObesitypatient careResearchrheumatologistrheumatology

Related Articles

    Mechanistic, Epidemiologic Clues Suggest Possible Link Between Obesity, Inflammation in Rheumatoid Arthritis

    October 11, 2016

    Obesity has an established systemic inflammatory component. Could that be a trigger for the inflammation seen in rheumatoid arthritis (RA) and other rheumatic diseases? Although there is no direct scientific evidence, both mechanistic and epidemiologic clues do give some intriguing suggestions of a possible link. “At first, we thought that fat was involved only in…

    Gout, Glucose Metabolism and Obesity: A Case Review

    November 2, 2014

    New research explores association between hyperurecimia and gout with metabolic derangement

    What Do Diabetes, Islet Cells & Autoimmunity Have in Common?

    August 15, 2017

    “Man may be the captain of his fate, but he is also the victim of his blood sugar.” —Wilfrid Oakley, MB BChir, an early pioneer in diabetes care Perusing the list of the most notable medical achievements in the 20th century, a reader may conclude that the discovery of insulin should rank in a category…

    Psoriatic Arthritis & the Obese Patient

    November 6, 2022

    Estimates from the National Psoriasis Foundation indicate that more than 8 million people in the U.S. suffer from psoriasis and that approximately 30% of those individuals develop psoriatic arthritis (PsA).1 Given these statistics, roughly 2.4 million people in the country are likely affected by PsA. Moreover, patients with this systemic condition carry a higher-than-average burden…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences